医师改良开窗/分支支架与杂交去分支联合支架置入治疗复杂胸腹主动脉瘤的比较
本研究回顾性分析了2016至2019年88例复杂胸腹主动脉瘤患者,其中60例(68%)接受医师改良开窗/分支支架(PMEG)治疗,28例(32%)接受杂交去分支联合支架置入术。总体30天死亡率为3.4%,PMEG组中期死亡率(3.3%)低于杂交组(7.1%)。结论认为两种技术均可行,PMEG可能具有更低的并发症率。
要点
- PMEG组240个目标血管中228个(95%)成功重建,杂交组110个目标血管全部成功重建。
- 总体30天死亡率为3.4%,早期目标血管狭窄/闭塞率为3.3%。
- PMEG组中期死亡率3.3%,低于杂交组的7.1%。
核心结论
- PMEG与杂交技术均为需内脏血管重建的主动脉瘤的可行治疗选择。
- PMEG可能具有比杂交技术更低的并发症率,但杂交技术仍是复杂主动脉瘤的重要选择。
研究设计与样本
- 回顾性分析2016至2019年88例复杂胸腹主动脉瘤患者,平均年龄70.0±10.6岁,73例男性。
- PMEG组60例(68%),杂交组28例(32%);平均动脉瘤直径64.5±11.7 mm,37例(42%)有症状。
主要发现
- PMEG组中35例使用4开窗支架,8例使用4分支支架,17例使用组合(50开窗和18分支),成功重建240个目标血管中的228个(95%)。
- 杂交组28例中110个目标血管全部通过旁路移植成功重建。
- 总体30天死亡率为3.4%(PMEG组2例,杂交组1例),早期目标血管狭窄/闭塞率为3.3%(PMEG组5例,杂交组6例)。
- 30天并发症主要包括肺部并发症(15%)、下肢缺血(8%)、脊髓缺血伴截瘫(6%);11例(13%)肾功能恶化,肾小球滤过率下降>30%。
- 平均随访22.3±4.9个月,总死亡率为4.5%(PMEG组3.3% vs 杂交组7.1%)。
临床怎么用
- 对于需内脏血管重建的复杂胸腹主动脉瘤,PMEG和杂交技术均可考虑。
- PMEG可能优先用于适合腔内修复且希望降低并发症风险的患者。
- 杂交技术仍可作为复杂主动脉瘤的重要备选方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose: To evaluate the immediate postoperative and midterm outcomes of complex thoracoabdominal aortic aneurysm (TAAA) treatment with fenestrated/branched physician-modified endovascular grafts (PMEGs) or open debranching of the visceral aorta with bypass graft revascularization plus endovascular aneurysm exclusion (hybrid repair). Materials and Methods: A retrospective analysis was conducted of 88 patients (mean age 70.0±10.6 years; 73 men) with complex TAAAs who underwent treatment with PMEGs (60, 68%) or a hybrid technique (28, 32%) between 2016 and 2019. The mean aneurysm diameter was 64.5±11.7 mm, and 37 patients (42%) were symptomatic. The Zenith TX2 and Ankura were the main stent-grafts used in the PMEG group. The hybrid technique involved visceral debranching with extra-anatomical bypass graft revascularization and subsequent stent-graft deployment (1- or 2-stage procedure). Results: In the PMEG group, 35 patients received modified stent-grafts with 4 fenestrations, 8 patients had 4 branches per device, and 17 patients had combinations (50 fenestrations and 18 branches) that successfully revascularized 228 of the 240 targets (95%). In the 28 hybrid cases, all 110 target vessels were successfully revascularized with bypass grafts. The overall 30-day mortality was 3.4% (2 PMEG and 1 hybrid), and the early rate of target vessel stenosis/occlusion was 3.3% (5 in PMEG group and 6 in the hybrid repair group). The 30-day morbidity was mainly attributed to pulmonary complications (15%), lower limb ischemia (8%), or spinal cord ischemia with paraplegia (6%). Eleven patients (13%) had deteriorated renal function with a >30% decrease in the glomerular filtration rate. The mean follow-up was 22.3±4.9 months, and mortality was 4.5% (3.3% in the PMEG group vs 7.1% in the hybrid repair group). Conclusion: PMEGs and hybrid techniques seem to be feasible treatment options for aortic aneurysms necessitating visceral vessel revascularization. PMEGs may have a lower morbidity than the hybrid technique, which nonetheless remains an important option available for complex aortic aneurysms.
引用
- Yang G, Zhang M, Muzepper M, et al. Comparison of Physician-Modified Fenestrated/Branched Stent-Grafts and Hybrid Visceral Debranching Plus Stent-Graft Placement for Complex Thoracoabdominal Aortic Aneurysm Repair. J Endovasc Ther. 2020. PMID: 32580618. doi:10.1177/1526602820934466
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。